文献速递儿科影像胸部US

新型肺超声评分法在新生儿呼吸窘迫综合征治疗中的应用价值

Application Value of a New Lung Ultrasound Scoring Method in Neonatal Respiratory Distress Syndrome Treatment.
PubMed 文献 · Ultrasound Med Biol · 2021-11-12

研究纳入88例接受肺表面活性物质替代治疗的新生儿呼吸窘迫综合征患儿,在治疗前及治疗后12、24、48、72小时采用14区肺超声评分法评估疗效;另对67例机械通气患儿在拔管时行肺超声评分,用ROC曲线分析拔管时机诊断效能。14区法在PS后12小时即显示与胸片一致的变化,预测拔管失败阈值为41.0分,AUC 0.955,敏感度92.4%,特异度93.8%。

要点

  • 14区肺超声评分在PS治疗后12小时即可显示显著变化,与胸片改变一致。
  • 拔管时14区肺超声评分以41.0分为阈值预测拔管失败风险,AUC 0.955。
  • 该阈值对应敏感度92.4%、特异度93.8%,诊断效能良好。

核心结论

  • 新型14区肺超声评分法可改善PS早期疗效的评分评估,并对NRDS机械通气拔管时机具有良好诊断效能。

研究设计与样本

  • 研究纳入88例接受PS替代治疗的NRDS新生儿,在PS前及PS后12、24、48、72小时行14区肺超声评分;另纳入67例机械通气NRDS患儿在拔管时行肺超声评分,用ROC曲线分析拔管时机诊断效能。

关键影像表现/征象

  • PS治疗后12小时,仅14区肺超声评分法与PS前差异有统计学意义(t=4.08,p<0.05),与胸片变化一致。
  • 其他肺超声评分法在PS后12小时与PS前差异无统计学意义(p>0.05)。

诊断标准与关键数值

  • 14区肺超声评分以41.0分为诊断阈值预测拔管失败风险,AUC为0.955。
  • 该阈值对应敏感度92.4%、特异度93.8%。

临床应用与阅片要点

  • 对接受PS治疗的NRDS患儿,可在PS后12小时采用14区肺超声评分评估早期疗效。
  • 对机械通气NRDS患儿,拔管时14区肺超声评分41.0分可用于预测拔管失败风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The study was aimed at exploring the clinical value of a 14-zone lung ultrasound scoring (LUS) method in treating neonatal respiratory distress syndrome (NRDS) with pulmonary surfactant (PS) and determining the timing of mechanical ventilation (MV). In this study, 88 neonates with NRDS who received PS replacement therapy were selected. We applied a new 14-zone LUS method before and 12, 24, 48 and 72 h after PS treatment to explore the clinical value of assessing PS replacement therapy efficacy in NRDS. Additionally, 67 patients with NRDS under MV received LUS during extubation. The receiver operating characteristic curve was used to analyze the diagnostic efficacy of LUS in the timing of extubation. LUS score was inversely associated with PS treatment. At 12 h after PS, only the 14-zone LUS method was significantly different (t = 4.08, p < 0.05) as compared with before PS, which was consistent with the change on chest x-ray (CXR); the other LUS methods did not differ (p > 0.05). The 14-zone LUS method exhibited better diagnostic performance for withdrawal time. A score of 41.0 points was used as the diagnostic threshold to predict the risk of withdrawal failure, with an area under the curve of 0.955, sensitivity of 92.4% and specificity of 93.8%. The new 14-zone LUS method improved scoring in the early efficacy of PS and had good diagnostic efficiency for timing the removal of MV in NRDS.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Jiang, Shi, Shen, et al. Application Value of a New Lung Ultrasound Scoring Method in Neonatal Respiratory Distress Syndrome Treatment. Ultrasound Med Biol. 2021. PMID: 34782166. doi:10.1016/j.ultrasmedbio.2021.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。